Patients in Alzheimer’s Drug Trials Not Told About Risks
The following information is from Public Citizen. Public Citizen, a nonprofit consumer advocacy organization, is calling for federal officials to investigate troubling practices in recent Alzheimer’s disease drug trials. A New York Times report reveals that participants in trials for two drugs—lecanemab […]
Patients in Alzheimer’s Drug Trials Not Told About Risks Read More »